FARALLON CAPITAL MANAGEMENT LLC Q4 2019 Filing
Filed February 13, 2020
Portfolio Value
$12.5T
Holdings
112
Report Date
Q4 2019
Filing Type
13F-HR
All Holdings (112 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —ABEONA THERAPEUTICS INC | 2,000,000 | $6.5B | 0.05% | |
| 102 | ARWRARROWHEAD PHARMACEUTICALS IN | 100,000 | $6.3B | 0.05% | |
| 103 | —PHASEBIO PHARMACEUTICALS INC | 1,000,000 | $6.1B | 0.05% | |
| 104 | —RADIUS HEALTH INC | 6,750,000 | $5.8B | 0.05% | |
| 105 | OYSTOYSTER POINT PHARMA INC | 230,800 | $5.6B | 0.05% | |
| 106 | ATRAGBXATARA BIOTHERAPEUTICS INC | 334,706 | $5.5B | 0.04% | |
| 107 | XRXXEROX HOLDINGS CORP | 130,000 | $4.8B | 0.04% | |
| 108 | OPKOPKO HEALTH INC | 2,500,000 | $3.7B | 0.03% | |
| 109 | —BROADMARK RLTY CAP INC | 7,174,613 | $2.7B | 0.02% | |
| 110 | —ZAFGEN INC | 1,808,360 | $2.0B | 0.02% | |
| 111 | —APTINYX INC | 408,549 | $1.4B | 0.01% | |
| 112 | —CYCLERION THERAPEUTICS INC | 350,000 | $952.0M | 0.01% |
PreviousPage 2 of 2